These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20308269)

  • 1. Cholesterol microembolization syndrome: a complication of anticoagulant therapy.
    Varis J; Kuusniemi K; Järveläinen H
    CMAJ; 2010 Jun; 182(9):931-3. PubMed ID: 20308269
    [No Abstract]   [Full Text] [Related]  

  • 2. Warfarin-related purple toes syndrome and cholesterol microembolization.
    Hyman BT; Landas SK; Ashman RF; Schelper RL; Robinson RA
    Am J Med; 1987 Jun; 82(6):1233-7. PubMed ID: 3605140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol microembolization syndrome.
    Kay JM
    CMAJ; 2010 Oct; 182(15):1647; author reply 1647. PubMed ID: 20956515
    [No Abstract]   [Full Text] [Related]  

  • 4. Purple toes and livido reticularis in a patient with cardiovascular disease taking coumadin. Cholesterol emboli associated with coumadin therapy.
    Park S; Schroeter AL; Park YS; Fortson J
    Arch Dermatol; 1993 Jun; 129(6):777, 780. PubMed ID: 8507086
    [No Abstract]   [Full Text] [Related]  

  • 5. Purple toes syndrome following stroke thrombolysis and warfarin therapy.
    Mooney T; Joseph P
    Intern Med J; 2014 Jan; 44(1):107-8. PubMed ID: 24450530
    [No Abstract]   [Full Text] [Related]  

  • 6. Cholesterol microembolization and stable renal function with continued anticoagulation.
    Acker CG
    South Med J; 1992 Feb; 85(2):210-2. PubMed ID: 1738893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral anticoagulant therapy: a precipitating factor in the pathogenesis of cholesterol embolization?
    Nevelsteen A; Kutten M; Lacroix H; Suy R
    Acta Chir Belg; 1992; 92(1):33-6. PubMed ID: 1553847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purple toes syndrome associated with warfarin therapy in a patient with antiphospholipid syndrome.
    Talmadge DB; Spyropoulos AC
    Pharmacotherapy; 2003 May; 23(5):674-7. PubMed ID: 12741443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The purple toe syndrome in female with Factor V Leiden mutation successfully treated with enoxaparin.
    Dulíček P; Bártová J; Beránek M; Malý J; Pecka M
    Clin Appl Thromb Hemost; 2013; 19(1):100-2. PubMed ID: 22531482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unusual side effects due to warfarin.
    Krahn MJ; Pettigrew NM; Cuddy TE
    Can J Cardiol; 1998 Jan; 14(1):90-3. PubMed ID: 9487280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case report: "purple toes" syndrome: an uncommon complication of oral anticoagulant therapy.
    Di Cato MA
    Postgrad Med; 1975 Dec; 58(7):133-4. PubMed ID: 1197146
    [No Abstract]   [Full Text] [Related]  

  • 12. Cholesterol crystal embolization caused by anticoagulant therapy.
    Cortez AF; Sakuma TH; Lima RB; de Figueiredo WM; Valle Hde A; Tolstoy FA; Coimbra DD; Lupi O
    Int J Dermatol; 2009 Sep; 48(9):989-90. PubMed ID: 19702986
    [No Abstract]   [Full Text] [Related]  

  • 13. Warfarin-associated multiple digital necrosis complicating heparin-induced thrombocytopenia and Raynaud's phenomenon after aortic valve replacement for adenocarcinoma-associated thrombotic endocarditis.
    Warkentin TE; Whitlock RP; Teoh KH
    Am J Hematol; 2004 Jan; 75(1):56-62. PubMed ID: 14695634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of unilateral purple toes due to warfarin.
    Al-Niaimi F; Clark C
    Clin Exp Dermatol; 2009 Jun; 34(4):527-8. PubMed ID: 19196305
    [No Abstract]   [Full Text] [Related]  

  • 15. Ask the doctor. Is warfarin turning my toes purple?
    Goldhaber SZ
    Harv Heart Lett; 2007 Jul; 17(11):7. PubMed ID: 17694613
    [No Abstract]   [Full Text] [Related]  

  • 16. Warfarin induced skin necrosis.
    Chan YC; Valenti D; Mansfield AO; Stansby G
    Br J Surg; 2000 Mar; 87(3):266-72. PubMed ID: 10718793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late onset purple toe syndrome with warfarin successfully treated with fondaparinux.
    Rindone JP; Mellen CK; Eliason JD
    Am J Ther; 2011 Nov; 18(6):e277-9. PubMed ID: 20535004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An interesting potential reaction to warfarin.
    Mc AG; Swinson B
    Dent Update; 2012; 39(1):33-4, 37. PubMed ID: 22720378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thromboembolic complication following temporary discontinuance of anticoagulant therapy in a patient with mechanical heart valve].
    Christensen TD; Houlind KC; Klaaborg KE; Kure HH; Eiskjaer H; Hasenkam JM
    Ugeskr Laeger; 2003 Jul; 165(28):2823-4. PubMed ID: 12891906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.
    Nielsen PB; Skjøth F; Søgaard M; Kjældgaard JN; Lip GY; Larsen TB
    BMJ; 2017 Feb; 356():j510. PubMed ID: 28188243
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.